Literature DB >> 30211613

Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall.

Jacobo Sellarés1,2,3, Mauricio Rojas4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30211613      PMCID: PMC6835043          DOI: 10.1165/rcmb.2018-0267ED

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  15 in total

1.  Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts.

Authors:  Hyun Lim; Haeil Park; Hyun Pyo Kim
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

2.  Licence to kill senescent cells in idiopathic pulmonary fibrosis?

Authors:  Arnaud A Mailleux; Bruno Crestani
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

Review 3.  Idiopathic Pulmonary Fibrosis.

Authors:  David J Lederer; Fernando J Martinez
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

4.  IPF lung fibroblasts have a senescent phenotype.

Authors:  Diana Álvarez; Nayra Cárdenes; Jacobo Sellarés; Marta Bueno; Catherine Corey; Vidya Sagar Hanumanthu; Yating Peng; Hannah D'Cunha; John Sembrat; Mehdi Nouraie; Swaroop Shanker; Chandler Caufield; Sruti Shiva; Mary Armanios; Ana L Mora; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

Review 5.  Idiopathic pulmonary fibrosis.

Authors:  Fernando J Martinez; Harold R Collard; Annie Pardo; Ganesh Raghu; Luca Richeldi; Moises Selman; Jeffrey J Swigris; Hiroyuki Taniguchi; Athol U Wells
Journal:  Nat Rev Dis Primers       Date:  2017-10-20       Impact factor: 52.329

6.  Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.

Authors:  Miriam S Hohmann; David M Habiel; Ana L Coelho; Waldiceu A Verri; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

7.  Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.

Authors:  Moisés Selman; Annie Pardo
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

Review 8.  The hallmarks of aging.

Authors:  Carlos López-Otín; Maria A Blasco; Linda Partridge; Manuel Serrano; Guido Kroemer
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

9.  Evaluating the Ameliorative Potential of Quercetin against the Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.

Authors:  Ramesh Verma; Lokendra Kushwah; Darpesh Gohel; Manish Patel; Tulsi Marvania; Suresh Balakrishnan
Journal:  Pulm Med       Date:  2013-12-12

10.  Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.

Authors:  Mareike Lehmann; Martina Korfei; Kathrin Mutze; Stephan Klee; Wioletta Skronska-Wasek; Hani N Alsafadi; Chiharu Ota; Rita Costa; Herbert B Schiller; Michael Lindner; Darcy E Wagner; Andreas Günther; Melanie Königshoff
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

View more
  5 in total

Review 1.  Update in Interstitial Lung Disease 2019.

Authors:  Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

Review 2.  Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery.

Authors:  Hani N Alsafadi; Franziska E Uhl; Ricardo H Pineda; Kolene E Bailey; Mauricio Rojas; Darcy E Wagner; Melanie Königshoff
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

3.  A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis.

Authors:  Albert Li; Jhih-Yu Chen; Chia-Lang Hsu; Yen-Jen Oyang; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

4.  Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells.

Authors:  Xuan Zhang; Ying Dong; Wan-Chen Li; Bi-Xi Tang; Jia Li; Yi Zang
Journal:  Acta Pharmacol Sin       Date:  2021-03-02       Impact factor: 6.150

Review 5.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.